Biosafety and differentially expressed genes analysis of melanoma cells treated with cold atmospheric plasma

J Biophotonics. 2022 Jun;15(6):e202100403. doi: 10.1002/jbio.202100403. Epub 2022 Mar 15.

Abstract

Cold atmospheric plasma (CAP) has attracted increasing attention due to its anti-bacterial and anti-tumor effects. Melanoma is an aggressive malignancy with increasing incidence rate and poor prognosis. Evaluating cell viability, apoptosis rate and reactive species injection efficiency of melanoma cells and human keratinocyte cells (HaCaT) treated with CAP to analyze biological safety of CAP. RNA-sequencing (RNA-seq) of A875 cells before and after treatment was performed to further explore the anti-tumor mechanism of CAP. CAP had a more significant biological effect on melanoma cells than HaCaT cells by inhibiting proliferation and promoting apoptosis. RNA-sequencing analysis showed that besides MAPK and p53 apoptotic signaling pathways, necroptosis and autophagy also played important roles in CAP-induced melanoma cells death. CAP can selectively kill melanoma cells and has good biosafety cytologically. Besides apoptosis, CAP can induce cell death via autophagy and necroptosis.

Keywords: RNA-sequencing; apoptosis; cold atmospheric plasma; melanoma.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis / genetics
  • Cell Line, Tumor
  • Containment of Biohazards
  • Humans
  • Melanoma* / genetics
  • Melanoma* / pathology
  • Plasma Gases* / pharmacology
  • RNA / pharmacology

Substances

  • Plasma Gases
  • RNA